Publicaciones en las que colabora con Estibaliz Castillero Olabarria (11)

2012

  1. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin

    Journal of Physiology and Pharmacology, Vol. 63, Núm. 6, pp. 649-659

  2. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats

    Growth Hormone and IGF Research, Vol. 22, Núm. 1, pp. 22-29

2011

  1. Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1

    Journal of Endocrinology, Vol. 210, Núm. 3, pp. 361-368

  2. Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 300, Núm. 5

2010

  1. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 299, Núm. 2

2009

  1. Cyclooxygenase-2 inhibition reverts the decrease in adiponectin levels and attenuates the loss of white adipose tissue during chronic inflammation

    European Journal of Pharmacology, Vol. 608, Núm. 1-3, pp. 97-103

  2. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 297, Núm. 5

  3. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting

    Molecular and Cellular Endocrinology, Vol. 309, Núm. 1-2, pp. 8-16

2008

  1. Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis

    Journal of Endocrinology, Vol. 197, Núm. 1, pp. 111-119

  2. Ptgs2 activation by endotoxin mediates the decrease in Igf1, but not in Igfbp3, gene expression in the liver

    Journal of Endocrinology, Vol. 198, Núm. 2, pp. 385-394

2006

  1. Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression

    Journal of Endocrinology, Vol. 190, Núm. 3, pp. 847-856